Loading clinical trials...

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT01391273

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes.

Lead sponsor: Allergan•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 4

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

NCT01023841 · Eyelash Hypotrichosis, Alopecia Areata

COMPLETEDPhase 4

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

NCT01229423 · Eyelash Hypotrichosis

COMPLETEDPhase 2

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

NCT01064882 · Eyelash Hypotrichosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 8, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment173

Start dateJul 2011

Last updatedJul 8, 2019

Condition

Eyelash Hypotrichosis

Locations shown

Tokyo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions